The findings supported that the overexpression of PAN3-AS1 was tied to poor OS of patients with two tumor types-adrenocortical carcinoma (ACC) and COAD, in contrast to patients with glioblastoma multiforme (GBM), lower grade glioma (LGG), PAAD, thymoma (THYM) and LUAD, in which patients with elevated PAN3-AS1 levels had favorable OS (Fig. 2A). Here, PAN3 is linked to central nervous system cancer.